News Releases

Therabron Therapeutics to Present at BioCentury 23rd Annual Future Leaders in the Biotech Industry Conference

ROCKVILLE, Md., Feb. 23, 2016 /PRNewswire/ -- Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that its President and Chief Executive Officer, Dr. Thomas F. Miller, will give a corporate presentation at the BioCentury 23rd Annual Future Leaders in the Biotech Industry Conference.  Additional information is as follows:


Friday, March 11, 2016


2:40 pm ET


Millennium Hotel

145 West 44th Street

Room 508

New York, NY

About Therabron Therapeutics, Inc.
At Therabron Therapeutics, we are advancing a platform of novel therapeutic proteins in an effort to change how a variety of neglected and under-treated respiratory and fibrotic conditions are managed.  We are a privately held, clinical-stage, biopharmaceutical company, developing a new class of drugs based on the naturally occurring secretoglobin family of proteins which includes the CC10 protein -- a molecule with both anti-inflammatory and immunomodulatory mechanisms.  Therabron's product candidates have the potential to become first-in-class, biologic therapeutics.  For additional information, please visit

SOURCE Therabron Therapeutics, Inc.

For further information: Media Relations, Michael Parks, Pitch360: 484.356.7105 or; Investor Relations, Melody Carey, Rx Communications Group LLC: 917.322.2571 or